JM 82 articles written Jimmy McDermott Latest Articles Type 2 FDA Approves Heart Protective Benefits of Trulicity new now next Read more FDA Approves Heart Protective Benefits of Trulicity Type 1 & Type 2 The Biggest News in Diabetes Technology from ATTD 2020 – A Deep Dive on CGM and more! new now next Read more The Biggest News in Diabetes Technology from ATTD 2020 – A Deep Dive on CGM and more! Type 1 & Type 2 How Physically Active is Your State? New Data From the CDC new now next Read more How Physically Active is Your State? New Data From the CDC Type 1 & Type 2 Steady Health’s Virtual Diabetes Clinic Emphasizes CGM and Coaching new now next Read more Steady Health’s Virtual Diabetes Clinic Emphasizes CGM and Coaching Type 2 FDA Approves Heart Protective Benefits of Ozempic and Confirms Safety of Rybelsus new now next Read more FDA Approves Heart Protective Benefits of Ozempic and Confirms Safety of Rybelsus Type 2 New Guidelines for Type 2 Diabetes Care – Emphasis on Heart and Kidney Health new now next Read more New Guidelines for Type 2 Diabetes Care – Emphasis on Heart and Kidney Health Type 1 Toujeo vs. Tresiba: How do they Compare on Time-in-Range in Type 1 Diabetes? trial watch Read more Toujeo vs. Tresiba: How do they Compare on Time-in-Range in Type 1 Diabetes? Type 1 How Does Exercise Affect Blood Sugar in Type 1 Diabetes? trial watch Read more How Does Exercise Affect Blood Sugar in Type 1 Diabetes? Type 2 FDA Recommends Recall of Extended-Release Metformin Due to Cancer-Causing Ingredient new now next Read more FDA Recommends Recall of Extended-Release Metformin Due to Cancer-Causing Ingredient Type 1 & Type 2 Tandem’s Control-IQ Cleared in United States new now next Read more Tandem’s Control-IQ Cleared in United States Pages« first ‹ previous 1 2 3 4 5 6 7 8 9 next › last »
Type 2 FDA Approves Heart Protective Benefits of Trulicity new now next Read more FDA Approves Heart Protective Benefits of Trulicity
Type 1 & Type 2 The Biggest News in Diabetes Technology from ATTD 2020 – A Deep Dive on CGM and more! new now next Read more The Biggest News in Diabetes Technology from ATTD 2020 – A Deep Dive on CGM and more!
Type 1 & Type 2 How Physically Active is Your State? New Data From the CDC new now next Read more How Physically Active is Your State? New Data From the CDC
Type 1 & Type 2 Steady Health’s Virtual Diabetes Clinic Emphasizes CGM and Coaching new now next Read more Steady Health’s Virtual Diabetes Clinic Emphasizes CGM and Coaching
Type 2 FDA Approves Heart Protective Benefits of Ozempic and Confirms Safety of Rybelsus new now next Read more FDA Approves Heart Protective Benefits of Ozempic and Confirms Safety of Rybelsus
Type 2 New Guidelines for Type 2 Diabetes Care – Emphasis on Heart and Kidney Health new now next Read more New Guidelines for Type 2 Diabetes Care – Emphasis on Heart and Kidney Health
Type 1 Toujeo vs. Tresiba: How do they Compare on Time-in-Range in Type 1 Diabetes? trial watch Read more Toujeo vs. Tresiba: How do they Compare on Time-in-Range in Type 1 Diabetes?
Type 1 How Does Exercise Affect Blood Sugar in Type 1 Diabetes? trial watch Read more How Does Exercise Affect Blood Sugar in Type 1 Diabetes?
Type 2 FDA Recommends Recall of Extended-Release Metformin Due to Cancer-Causing Ingredient new now next Read more FDA Recommends Recall of Extended-Release Metformin Due to Cancer-Causing Ingredient
Type 1 & Type 2 Tandem’s Control-IQ Cleared in United States new now next Read more Tandem’s Control-IQ Cleared in United States
